Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Overgrowth and Macrocephaly Syndromes Panel PreventionGenetics, part of Exact Sciences United States | 145 | 112 |
|
PTCH1 gene sequence and deletion/duplication Ambry Genetics United States | 3 | 1 |
|
Holoprosencephaly-7 (Autosomal Dominant, Nonsyndromic) via the PTCH1 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Holoprosencephaly, Autosomal Dominant, Nonsyndromic, Panel PreventionGenetics, part of Exact Sciences United States | 10 | 14 |
|
Hereditary pediatric cancer panel. NGS panel of 71 genes. Genologica Medica Spain | 158 | 71 |
|
Macrocephaly / overgrowth syndrome panel. 43-gene NGS panel. Genologica Medica Spain | 88 | 43 |
|
Holoprosencephaly panel. 12-gene NGS panel. Genologica Medica Spain | 27 | 12 |
|
GeneDx United States | 103 | 82 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 3 | 1 |
|
Fulgent Genetics United States | 127 | 23 |
|
Gorlin Syndrome (PTCH1 Single Gene Test) Fulgent Genetics United States | 3 | 1 |
|
Macrocephaly/Overgrowth Syndrome NGS Panel Fulgent Genetics United States | 100 | 38 |
|
Holoprosencephaly Panel, Sequencing and Deletion/Duplication, Fetal ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 9 | 8 |
|
Comprehensive Hereditary Cancer Panel Baylor Genetics United States | 132 | 61 |
|
Hereditary Brain, CNS, PNS Cancer Panel Baylor Genetics United States | 43 | 17 |
|
Hereditary Brain, CNS, PNS Cancer Panel Baylor Genetics United States | 43 | 17 |
|
Fulgent Genetics United States | 645 | 26 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 329 | 127 |
|
Nervous System / Brain Cancer Comprehensive Panel Fulgent Genetics United States | 133 | 27 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.